Dr. Michal Heger is the Editor-in-Chief of the Journal of Clinical and Translational Research and Professor in the Department of Experimental Surgery, Academic Medical Center, University of Amsterdam, Amsterdam in the Netherlands. He is also the Founder and CEO of Sickel and Hammer Services as well as the CEO and Co-Founder of Applive LTD. Dr. Heger is an expert in clinical and translational research with the patient at the very centerfold, which is why he founded his own professional journal in that name Journal of Clinical and Translational Research; (JCTR) The target audience is comprised of medical patients, clinicians and researchers, which ultimately represent consumers, individuals and families. Dr. Heger completed his graduate studies at the University of Utrecht, Utrecht, the Netherlands. Dr. Heger is currently the principal investigator at the Department of Experimental Surgery at the Academic Medical Center, University of Amsterdam. His research is predominantly focused on the following areas: (1) hepatic and renal ischemia/reperfusion injury; (2) hepatic steatosis; (3) cholestasis; (4) portal vein embolization and liver regeneration; (5) liver and kidney transplantation and preservation techniques; (6) chemotherapy and photodynamic therapy of solid cancers; (7) laser-assisted vascular welding. His academic research responsibilities further include development and employment of micro- and spectroscopic techniques for the assessment of tissue viability and function as well as setting up novel animal models and biochemical/chemical assays, treatment techniques, and research lines within the scope of existing and novel research activities.
Dr. Heger specializes in these areas: